companydata.dkGXP PHARMAID ApS: Financial statements 2017
CVR: 29615861
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,410,169 and a net result of DKK 142,289 compared with DKK 97,377 the year before. That is a decrease of 13.6% compared with the year before. Equity amounted to DKK 686,684. The solvency ratio was 36%. The company had 1 employee in the financial year.
- Gross Profit
- 1,410,169 kr.
- Profit/Loss
- 142,289 kr.
- Equity
- 686,684 kr.
- Total Assets
- 1,905,490 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.4 mio. | 142 t. | 687 t. | 1 |
| 2016 | - | 1.6 mio. | 97 t. | 544 t. | - |
| 2015 | - | 1.9 mio. | -667 t. | 447 t. | - |
| 2014 | - | 3.6 mio. | 380 t. | 1.1 mio. | - |
| 2013 | - | 2.3 mio. | 451 t. | 1.1 mio. | - |
Events in 2017
As of December 11, 2017, EMIT P/S has been appointed auditor of GXP PHARMAID ApS.
As of December 11, 2017, TIMEVISION FREDERIKSBERG REGISTRERET REVISIONSAKTIESELSKAB has stepped down as auditor of GXP PHARMAID ApS.
GXP PHARMAID ApS has published its annual report for 2016. Gross profit came to DKK 1,632,757, and the net result was DKK 97,377.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. Equity amounted to DKK 1,096,211.